Sabiedrība ar ierobežotu atbildību "MEDPRO INC."

Key FactsEnterprise Register · 22/02/2021

Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 28/07/2017
SEPA code: LV39ZZZ40203083914
Address: Rīga, Ģertrūdes iela 15/17
Region: 0
Equity capital: €2,800
NACE code: 21.1021.10 Manufacture of basic pharmaceutical products
Industry sector: CC › 21 › 21.1 › 21.10
Historical names: —

StatusEnterprise Register · 22/02/2021

No issues detected

InsolvencyNone

LiquidationNone

VID suspensionsNone

SanctionsNone

Securing measuresNone

ReorganizationNone

Key Financials (2024)data for 2024

Revenue

€0

Net income

-€50

Total assets

€2,745

Equity capital

€2,395

Employees

Profit margin

—

Current Ratio

54.90

ROA

-1.8%

Financial History

Insufficient data

ShareholdersEnterprise Register · 22/02/2021

JUR.Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS"

2,800

Beneficial Owners

Ēriks MasteikoLV

Officials

Executive Board

Masteiko Ēriks

Board Member

Power of AttorneyEnterprise Register · 22/02/2021

No prokūra data

Timeline

22/02/2021

UBO declared: Ēriks Masteiko

Ēriks Masteiko

28/07/2017

Company registered

28/07/2017

BOARD_MEMBER, EXECUTIVE_BOARD appointed: Masteiko Ēriks

Masteiko Ēriks

28/07/2017

SIA shareholder: Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" (2800 shares)

Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" (2800 shares)

28/07/2017

Capital: Apmaksātais pamatkapitāls 2800 EUR

2800 EUR

17/07/2017

Founding registered

13/07/2017

Founding decision signed

Key FactsEnterprise Register · 22/02/2021

Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 28/07/2017
SEPA code: LV39ZZZ40203083914
Address: Rīga, Ģertrūdes iela 15/17
Region: 0
Equity capital: €2,800
NACE code: 21.1021.10 Manufacture of basic pharmaceutical products
Industry sector: CC › 21 › 21.1 › 21.10
Historical names: —

StatusEnterprise Register · 22/02/2021

No issues detected

InsolvencyNone

LiquidationNone

VID suspensionsNone

SanctionsNone

Securing measuresNone

ReorganizationNone

Key Financials (2024)data for 2024

Revenue

€0

Net income

-€50

Total assets

€2,745

Equity capital

€2,395

Employees

Profit margin

—

Current Ratio

54.90

ROA

-1.8%

Financial History

Insufficient data

ShareholdersEnterprise Register · 22/02/2021

JUR.Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS"

2,800

Beneficial Owners

Ēriks MasteikoLV

Officials

Executive Board

Masteiko Ēriks

Board Member

Power of AttorneyEnterprise Register · 22/02/2021

No prokūra data

Timeline

22/02/2021

UBO declared: Ēriks Masteiko

Ēriks Masteiko

28/07/2017

Company registered

28/07/2017

BOARD_MEMBER, EXECUTIVE_BOARD appointed: Masteiko Ēriks

Masteiko Ēriks

28/07/2017

SIA shareholder: Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" (2800 shares)

Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" (2800 shares)

28/07/2017

Capital: Apmaksātais pamatkapitāls 2800 EUR

2800 EUR

17/07/2017

Founding registered

13/07/2017

Founding decision signed